Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: ARVN) | Delayed: 7.62 -0.02 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.64 | 52 Week High | $ | |||
| Open | $7.73 | 52 Week Low | $ | |||
| Day High | $7.73 | P/E | N/A | |||
| Day Low | $7.52 | EPS | $ | |||
| Volume | 65,167 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.32 +0.04 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.42 | 52 Week Low | $28.25 | |||
| Day High | $28.50 | P/E | 17.16 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 5,115,224 | |||||
